Pyruvate kinase type M2 and its role in tumor growth and spreading.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Seminars in Cancer Biology

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.SEMCANCER.2005.04.009PMID 15908230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation Of Carbohydrate Metabolism

  2018cited by this paper
• Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.

  2004cited by this paper
• Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma

  2004cited by this paper
• Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer

  2004cited by this paper
• Phosphoglycerate Mutase-derived Polypeptide Inhibits Glycolytic Flux and Induces Cell Growth Arrest in Tumor Cell Lines*

  2004cited by this paper
• Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2‐PK) as a tumor marker for cervical carcinoma

  2004cited by this paper
• Tumor M2-Pyruvate Kinase, a New Metabolic Marker for Pancreatic Cancer

  2004cited by this paper
• Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines

  2004cited by this paper
• Histamine, Part of the Metabolome

  2003cited by this paper
• Interaction between HERC1 and M2‐type pyruvate kinase

  2003cited by this paper
• Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence.

  2003cited by this paper
• The tumor metabolome.

  2003cited by this paper
• Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.

  2003cited by this paper
• Regulation of glycolysis by Raf protein serine/threonine kinases.

  2002cited by this paper
• Metabolic profiling of cell growth and death in cancer: applications in drug discovery.

  2002cited by this paper
• Pyruvate kinase type M2: a crossroad in the tumor metabolome

  2002cited by this paper
• Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.

  2002cited by this paper
• Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7

  2001cited by this paper
• Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.

  2001cited by this paper
• Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.

  2000cited by this paper
• Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

  2000cited by this paper
• The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer.

  2000cited by this paper
• Tumor type M2 pyruvate kinase expression in advanced breast cancer.

  2000cited by this paper
• The onset and extent of genomic instability in sporadic colorectal tumor progression.

  1999cited by this paper
• Book Reviews

  1999cited by this paper
• The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.

  1999cited by this paper
• Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats

  1999cited by this paper
• TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions.

  1999cited by this paper
• Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).

  1999cited by this paper
• Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

  1999cited by this paper
• Quantitative detection of tumor M2-PK in serum and plasma.

  1999cited by this paper
• Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors.

  1998cited by this paper
• Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications.

  1998cited by this paper
• Metabolic characteristics of different malignant cancer cell lines.

  1998cited by this paper
• Expression of hypoxia-inducible genes in tumor cells

  1998cited by this paper
• Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet.

  1998cited by this paper
• Dependence of energy metabolism on the density of cells in culture.

  1998cited by this paper
• Oxidation of glutamine in HeLa cells: Role and control of truncated TCA cycles in tumour mitochondria

  1998cited by this paper
• Hypoxia Regulates β-Enolase and Pyruvate Kinase-M Promoters by Modulating Sp1/Sp3 Binding to a Conserved GC Element*

  1998cited by this paper
• Double role of pyruvate kinase type M2 in the regulation of phosphometabolite pools

  1998cited by this paper
• The Role of Phosphometabolites in Cell Proliferation, Energy Metabolism, and Tumor Therapy

  1997cited by this paper
• Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.

  1997cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Effect of Extracellular AMP on Cell Proliferation and Metabolism of Breast Cancer Cell Lines with High and Low Glycolytic Rates*

  1997cited by this paper
• The Oxidative Metabolism of Glutamine

  1996cited by this paper
• Studies on associations of glycolytic and glutaminolytic enzymes in MCF‐7 cells: Role of P36

  1996cited by this paper
• p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins.

  1996cited by this paper
• Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine-induced rat hepatomas: possible involvement of oxygen free radicals.

  1995cited by this paper
• Glyceraldehyde-3-phosphate Dehydrogenase Selectively Binds AU-rich RNA in the NAD+-binding Region (Rossmann Fold) (*)

  1995cited by this paper
• Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio.

  1994cited by this paper
• Chapter 10 – Carbohydrate Metabolism and Neoplasia: New Perspectives for Diagnosis and Therapy

  1994cited by this paper
• Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains?

  1994cited by this paper
• Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.

  1992cited by this paper
• Intracellular ribonucleotide pools as a tool for monitoring the physiological state of in vitro cultivated mammalian cells during production processes

  1992cited by this paper
• Phosphorylation of pyruvate kinase type K is restricted to the dimeric form.

  1992cited by this paper
• Pyruvate Kinase in Selected Human Tumors

  1991cited by this paper
• In situ lactate dehydrogenase patterns as markers of tumour oxygenation.

  1991cited by this paper
• In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate.

  1991cited by this paper
• Pathway of glutamate oxidation and its regulation in the HuH13 line of human hepatoma cells

  1991cited by this paper
• Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells.

  1990cited by this paper
• Transforming collaborations between ras and nuclear oncogenes.

  1990cited by this paper
• Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

  1989cited by this paper
• Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus

  1988cited by this paper
• Experimental cancer therapy in mice by adenine nucleotides.

  1988cited by this paper
• The ras gene family and human carcinogenesis.

  1988cited by this paper
• The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing.

  1986cited by this paper
• Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism.

  1986cited by this paper
• The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells.

  1986cited by this paper
• The function of redox shuttles during aerobic glycolysis in two strains of Ehrlich ascites tumor cells.

  1985cited by this paper
• Glycolysis, glutaminolysis and cell proliferation.

  1982cited by this paper
• Cytosolic malic dehydrogenase activity is associated with a putative substrate for the transforming gene product of Rous sarcoma virus.

  1982cited by this paper
• Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-Pk) in tumors of chicken and rat

  1981cited by this paper
• Purine and pyrimidine nucleotide patterns of normal, differentiating, and regenerating liver and of hepatomas in rats.

  1980cited by this paper
• Inhibition of animal and invertebrate cell growth by naturally occurring purine bases and ribonucleosides.

  1980cited by this paper
• Levels of 2,3-diphosphoglycerate in Friend leukaemic cells

  1980cited by this paper
• Glycolysis—one of the keys to cancer?

  1980cited by this paper
• Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

  1979cited by this paper
• Evidence for the oxidation of glycolytic NADH by the malate-aspartate shuttle in Ehrlich ascites tumor cells.

  1979cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• On the origin of cancer cells.

  1956cited by this paper

• Nanomedicine-based lactate metabolism and lactylation regulation for exploring new therapeutic strategies in cancer.

  2026cites this paper
• Impact of Hypoxia-inducible factor 1 in the oncogenic progression of Kaposi's sarcoma-associated herpes virus.

  2026cites this paper
• Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights

  2026cites this paper
• Metabolic reprograming of immune cells in MASH.

  2025cites this paper
• Targeting PKM2 in cancer therapeutics: mechanistic advances and translational opportunities

  2025cites this paper
• Halicin Reduces the Warburg Effect and Overcomes Drug Resistance by Activating the Pyruvate Kinase M2 Pathway for Triple-Negative Breast Cancer Treatment

  2025cites this paper
• HBx Drives Liver Cancer Stem Cell Generation Through Stimulating Glucose Metabolic Reprogramming

  2025cites this paper
• Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties

  2025cites this paper
• Investigation and Distinction of Energy Metabolism in Proliferating Hepatocytes and Hepatocellular Carcinoma Cells

  2025cites this paper
• Impact of mtG3PDH inhibitors on proliferation and metabolism of androgen receptor-negative prostate cancer cells: Role of extracellular pyruvate

  2025cites this paper
• CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models

  2025cites this paper
• The glycolytic enzyme PKM2 regulates inflammatory osteoclastogenesis by modulating STAT3 phosphorylation

  2025cites this paper
• Targeting Pyruvate Kinase: Novel Therapeutic Strategies in Metabolic and Blood Disorders

  2025cites this paper
• The unusual metabolism of germinal center B cells.

  2025cites this paper
• PKM2: A novel helmsman of lipid metabolism.

  2025cites this paper
• The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance

  2025cites this paper
• Discovery of PKM2 activators from Aconiti Lateralis Radix Praeparata via computer-aided drug design and experimental validation.

  2025cites this paper
• Novel Targets for Treating Neurodegenerative Diseases: The PKM2-STAT3-hnRNPA1 Feedback Loop.

  2025cites this paper
• Unravelling Shared Pathways Linking Metabolic Syndrome, Mild Cognitive Impairment, Dementia, and Sarcopenia

  2025cites this paper
• Catabolic rewiring in cancer impacts dietary interventions

  2025cites this paper
• PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth.

  2025cites this paper
• Palmitic Acid Accelerates Endothelial Cell Injury and Cardiovascular Dysfunction via Palmitoylation of PKM2

  2024cites this paper
• Search progress of pyruvate kinase M2 (PKM2) in organ fibrosis

  2024cites this paper
• Each big journey starts with a first step: Importance of oligomerization.

  2024cites this paper
• PKM2 is a key factor to regulate neurogenesis and cognition by controlling lactate homeostasis

  2024cites this paper
• MicroRNA-122 regulates inflammatory and autophagic proteins by downregulating pyruvate kinase M2 in non-alcoholic fatty liver disease

  2024cites this paper
• A comprehensive analysis of the pyruvate kinase M1/2 (PKM) in human cancer.

  2024cites this paper
• Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer

  2024cites this paper
• Autophagy in glioblastoma: A mechanistic perspective

  2024cites this paper
• Metabolic adaptations in cancer stem cells: A key to therapy resistance.

  2024cites this paper
• Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications

  2024cites this paper
• Interplay between altered metabolism and DNA damage and repair in ovarian cancer

  2024cites this paper
• N-terminal domain truncation yielded a unique dimer of polysaccharide hydrolase with enhanced enzymatic activity, stability and calcium ion independence.

  2024cites this paper
• Tetramerization of pyruvate kinase M2 attenuates graft-versus-host disease by inhibition of Th1 and Th17 differentiation

  2024cites this paper
• Effect of HPV Oncoprotein on Carbohydrate and Lipid Metabolism in Tumor Cells.

  2024cites this paper
• Targeting the Metabolic Paradigms in Cancer and Diabetes

  2024cites this paper
• Research Progress of New Urine Markers in the Diagnosis of Bladder Cancer

  2024cites this paper
• Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.

  2024cites this paper
• Nuclear PKM2 binds pre-mRNA at folded G-quadruplexes and reveals their gene regulatory role.

  2024cites this paper
• Readers of RNA Modification in Cancer and Their Anticancer Inhibitors

  2024cites this paper
• Gene Expression of Glycolysis Enzymes in MCF-7 Breast Cancer Cells Exposed to Warburg Effect and Hypoxia

  2024cites this paper
• Cardiac Metabolism.

  2024cites this paper
• Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets

  2024cites this paper
• RBBP7, regulated by SP1, enhances the Warburg effect to facilitate the proliferation of hepatocellular carcinoma cells via PI3K/AKT signaling

  2024cites this paper
• Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

  2024cites this paper
• Expression Regulation of Gluconeogenesis Related Genes in Ovine Skeletal Muscle Cells.

  2024cites this paper
• Regulatory Role of Autophagy and Glucose Metabolic Reprogramming in the Malignant Progression of Bladder Cancer: A Review

  2024cites this paper
• Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action

  2024cites this paper
• Molecular Modeling of Single- and Double-Hydrocarbon-Stapled Coiled-Coil Inhibitors against Bcr-Abl: Toward a Treatment Strategy for CML

  2024cites this paper
• Emodin disrupts the KITENIN oncogenic complex by binding ErbB4 and suppresses colorectal cancer progression in dual blockade with KSRP-binding compound.

  2024cites this paper
• Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer

  2024influential citation
• USP25-PKM2-glycolysis axis contributes to ischemia reperfusion-induced acute kidney injury by promoting M1-like macrophage polarization and proinflammatory response.

  2023cites this paper
• Aldehyde accumulation in Mycobacterium tuberculosis with defective proteasomal degradation results in copper sensitivity

  2023cites this paper
• Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver

  2023cites this paper
• Protein Oligomer Engineering: A New Frontier for Studying Protein Structure, Function, and Toxicity.

  2023cites this paper
• Knockdown of pyruvate kinase M2 suppresses bladder cancer progression

  2023cites this paper
• CB2R agonist GW405833 alleviates acute liver failure in mice via inhibiting HIF-1α-mediated reprogramming of glycometabolism and macrophage proliferation

  2023cites this paper
• Unique Metabolic Contexts Sensitize Cancer Cells and Discriminate between Glycolytic Tumor Types

  2023cites this paper
• Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC

  2023cites this paper
• A reduced model of cell metabolism to revisit the glycolysis-OXPHOS relationship in the deregulated tumor microenvironment.

  2023cites this paper
• Serum Metabolomic Profiling of Patients with Lipedema

  2023cites this paper
• The Aurora kinase inhibitor AT9283 inhibits Burkitt lymphoma growth by regulating Warburg effect

  2023cites this paper
• Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer

  2023cites this paper
• An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review.

  2023cites this paper
• The PKM2 inhibitor shikonin enhances piceatannol‐induced apoptosis of glyoxalase I‐dependent cancer cells

  2023cites this paper
• PKM2 Nuclear Translocation Promotes Glial Cell Activation and Aggravates the Brain Injury of Intracerebral Hemorrhage.

  2023cites this paper
• Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review.

  2023cites this paper
• Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma

  2023cites this paper
• Hepatocellular Ballooning is Due to Highly Pronounced Glycogenosis Potentially Associated with Steatosis and Metabolic Reprogramming

  2023cites this paper
• 2′-Hydroxycinnamaldehyde mitigates acetaminophen-induced acute liver injury by inhibiting the Warburg effect-mediated pyroptosis via the PKM2-NLRP3 axis

  2023cites this paper
• The Interaction Between Apigenin and PKM2 Restrains Progression of Colorectal Cancer.

  2023cites this paper
• Evaluating the Anti-Melanoma Effects and Toxicity of Cinnamaldehyde Analogues

  2023cites this paper
• Validation of Faecal Pyruvate Kinase Isoenzyme Type M2 (Faecal M2PK Quick) Test in Detection of Colorectal Adenoma and Adenocarcinoma Among High-Risk Malaysian Population

  2023cites this paper
• Metabolic Reprogramming toward Aerobic Glycolysis and the Gut Microbiota Involved in the Brain Amyloid Pathology

  2023cites this paper
• Scutellarein treats neuroblastoma by regulating the expression of multiple targets

  2023cites this paper
• Correlation of PKM2 Expression With HER2/neu and Additional Breast Cancer Biomarkers and its Prognostic Significance

  2023cites this paper
• Role of HIF in fish inflammation.

  2023cites this paper
• Evaluation of pyruvate kinase and oxidative stress parameters in differentiation between transudate and exudate in pleural liquids

  2023influential citation
• Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis

  2023cites this paper
• Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma.

  2023cites this paper
• The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies

  2023cites this paper
• Computational Modeling of Stapled Coiled-Coil Inhibitors Against Bcr-Abl: Toward a Treatment Strategy for CML

  2023cites this paper
• Moonlight functions of glycolytic enzymes in cancer

  2023cites this paper
• Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma

  2023cites this paper
• Oral spatial-to-point cascade targeting "sugar-coated bullets" for precise and safe chemotherapy by intervention Warburg effect.

  2022cites this paper
• An Update on the Metabolic Landscape of Oncogenic Viruses

  2022cites this paper
• FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes

  2022cites this paper
• Lysine succinylation, the metabolic bridge between cancer and immunity

  2022cites this paper
• Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession

  2022cites this paper
• Aldehyde inactivation of the RicR regulon sensitizes Mycobacterium tuberculosis to copper

  2022cites this paper
• Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis.

  2022cites this paper
• Extracellular Hsp90α Supports the ePKM2-GRP78-AKT Axis to Promote Tumor Metastasis

  2022cites this paper
• Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma

  2022influential citation
• Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion

  2022cites this paper
• The CXCL12/CXCR4/ACKR3 Signaling Axis Regulates PKM2 and Glycolysis

  2022cites this paper
• Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis

  2022cites this paper
• Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs

  2022cites this paper
• Metabolická plasticita nádorových buněk Metabolic plasticity of cancer cells

  2022cites this paper
• Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages.

  2022cites this paper
• Functions and modulation of PKM2 activity by human papillomavirus E7 oncoprotein (Review)

  2022cites this paper